MAXIA PHARMACEUTICALS
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs.
MAXIA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Contact:
(858)824-1988
Total Funding:
0
Similar Organizations
DS Biopharma
DS Biopharma is a privately held drug discovery and development company.
MerLion Pharma
MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.
NanoPacific Holdings
NanoPacific Holdings (NPH) is a privately held research and development company based in Los Angeles,
Promiliad Biopharma
Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.
Investors List
Bay City Capital
Bay City Capital investment in Venture Round - Maxia Pharmaceuticals
More informations about "Maxia Pharmaceuticals"
Maxia Pharmaceuticals - PitchBook
How much funding has Maxia Pharmaceuticals raised over time? Maxia Pharmaceuticals has raised $28M. Who are Maxia Pharmaceuticals’s investors? Bay City Capital, Ironbark Asset …See details»
Maxia Pharmaceuticals - Crunchbase
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Maxia Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Maxia Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:MX-6162, MX-895, MX-781, MX-7091, MX-6043.See details»
Maxia Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 10835 Altman Row Suite 250. San Diego, California, 92121, United States. 858-824-1988See details»
Maxia Pharmaceuticals Inc - Company Profile and News
Company profile page for Maxia Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Maxia Pharmaceutical - Ownership and Business Overview - Mergr
Feb 18, 2003 Maxia Pharmaceutical is a life science company. Life Science M&A Summary in 2003 Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2003 .See details»
Maxia Pharma - Bay City Capital
Maxia Pharma. Formed to exploit the non-dermatological applications of a patented library of compounds licensed from Galderma. The company focused on small molecule drugs that …See details»
Incyte acquires Maxia Pharmaceuticals - 2003-02-18 - Crunchbase
Feb 18, 2003 Maxia Pharmaceuticals Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs. Acquiring Organization: …See details»
Maxia Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Maxia Pharmaceuticals Inc is a company that provides Drug discovery, Medicine, Molecule and more. Maxia Pharmaceuticals Inc is headquartered in United States California. Maxia …See details»
Maxia Pharmaceuticals, Inc. (Maxia Pharmaceuticals, Inc.) - 药 …
了解Maxia Pharmaceuticals, Inc. (Maxia Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的4篇文献，药物:MX-7220，MX-895，MX-6162，MX-6043，MX-7091。See details»
MAXIA PHARMACEUTICALS, INC. - Maxia Pharmaceuticals, Inc.
Owner: Maxia Pharmaceuticals, Inc. Address: 10835 Altman Row Suite 250 San Diego DE 92121: Legal Entity Type: Corporation: Legal Entity State: DESee details»
Maxia Pharmaceuticals - CB Insights
Explore {Maxia Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Maxia …See details»
Incyte in $43M deal to buy Maxia Pharma - Pharmaceutical …
Mar 3, 2003 California, USA-based Incyte Genomics has completed the acquisition ofprivately-held drug discovery firm Maxia Pharmaceuticals in a deal worth around $43 million. Under the …See details»
Maxia Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Maxia Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Maxia Pharmaceuticals's post-money valuation and revenue. Maxia …See details»
Maxia Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Mar 26, 2023 Maxia Pharmaceuticals, Inc. is a company that provides Drug discovery, Medicine, Small molecule and more. Maxia Pharmaceuticals, Inc. is headquartered in United States …See details»
Maxia Pharmaceuticals, Inc. - US Patent and Trademark Search
Maxia pharmaceuticals inc uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office …See details»
Maxia Pharmaceuticals - Funding, Financials, Valuation & Investors
Nov 1, 1997 Maxia Pharmaceuticals has raised 1 round. This was a Venture - Series Unknown round raised on Nov 1, 1997 . Maxia Pharmaceuticals is funded by Bay City Capital .See details»
Incyte Buying Maxia For $28.3M; Plans Staff, Expense Reductions
Nov 13, 2002 Incyte Genomics Inc., known for its databases and research solutions, is acquiring Maxia Pharmaceuticals Inc. and its pipeline of early stage drugs for an amount that could …See details»
MX-6162 - Drug Targets, Indications, Patents - Synapse - Patsnap
MX-6162, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Skin and Musculoskeletal Diseases. ...See details»
MX-7220 - Drug Targets, Indications, Patents - Synapse - Patsnap
MX-7220, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Respiratory Diseases ...See details»